6MARCHANT F E, LOWRY I. D, MOFFIT J J, et al. Current trends in posttreatment follow-up of patients with squamous cell carcinoma of the head and neck[J]. Am J Otolaryngol, 1993,14:88- 93.
7SCOLA B, FERNANDEZ-VEGA M, MARTINEZ T, et al. Management of cancer of the supraglottis [J]. Otolaryngol Head Neck Surg,2001,124: 195-- 199.
8BRENNAN J A, MAO L, HRUBAN R H, et al. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck[J]. N Engl J Med, 1995, 332: 429--435.
9KWON S Y, KIM H J, WOO J S, et al . The usefulness of cytokeratin immunohistochemistry in detection of lymph node micrometastasis in neck dissection specimens[J]. Otolaryngol Head Neck Surg, 2004, 131: 300--306.
10KOCATUERK S, YILMAZER D, OENAL B, et al. Do micrometastases detected with cytokeratin immunoperoxidase reactivity affect the treatment approach to neck in supraglottic cancers[J]? Otolaryngol Head Neck Surg,2003,127:407-- 411.
